Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Authors: John A. Spertus, Jennifer Fine, Perry Elliott, Carolyn Y. Ho, Iacopo Olivotto, Sara Saberi, Wanying Li, Chantal Dolan, Matthew Reaney, Amy J. Sehnert, Daniel Jacoby - The Lancet 2021 cited by 215